BioCryst Pharmaceuticals ...

8.39
0.17 (2.07%)
At close: Apr 25, 2025, 3:59 PM
8.40
0.06%
After-hours: Apr 25, 2025, 05:49 PM EDT

BioCryst Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
450.71M 331.41M 270.83M 157.17M 17.81M 48.84M 20.65M 25.19M 26.35M
12.27M 4.66M 6.59M 7.26M 1.68M 4.1M 471K 1.7M 2.7M
438.44M 326.75M 264.23M 149.91M 16.14M 44.73M 20.18M 23.48M 23.65M
-2.54M -103.71M -148.44M -177.72M -174.76M -99.45M -94.22M -57.41M -48.61M
14.75M 15.78M 5.13M 62K 9.42M 1.93M 2.25M 1.01M 793K
-86.95M -226.23M -244.38M -181.81M -182.81M -108.9M -101.25M -65.78M -55.14M
-88.88M -226.54M -247.12M -184.06M -196.57M -120.06M -101.25M -65.78M -55.14M
266.13M 213.89M 159.37M 118.82M 67.93M 37.12M 29.51M 13.93M 11.25M
174.64M 216.57M 253.3M 208.81M 122.96M 107.07M 84.89M 66.96M 61.01M
216K n/a 253.27M 202.92M 111.96M 82.44M 70.81M 54.38M 47.01M
440.99M 430.46M 412.67M 327.63M 190.89M 144.19M 114.4M 80.89M 72.26M
98.52M 108.24M 99.09M 59.29M 14.5M 11.89M 9.18M 8.56M 6.49M
n/a 14.4M 14.89M 5.71M 6.57M n/a n/a n/a n/a
453.25M 435.12M 419.26M 334.89M 192.57M 148.29M 114.87M 82.6M 74.96M
1.93M 310K 2.73M 2.25M 13.75M 11.17M 2.14M 7.86M 6M
206.7M 192.2M 185.91M 179.12M 167.27M 115.6M 103.19M 84.45M 73.7M
206.7M 192.2M 185.91M 179.12M 167.27M 115.6M 103.19M 84.45M 73.7M
-0.43 -1.18 -1.33 -1.03 -1.18 -1.04 -0.98 -0.78 -0.75
-0.43 -1.18 -1.33 -1.03 -1.18 -1.04 -0.98 -0.78 -0.75
12.81M -116.33M -143.85M -121.74M -167.56M -96.28M -90.36M -56.51M -48.17M
11.56M -117.99M -145.29M -122.52M -168.31M -97M -92.08M -57.22M -48.66M
1.25M 1.66M 1.44M 777K 748K 724K 770K 704K 483K